Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, November 3, 2022
[ Thu, Nov 03rd 2022
] - WOPRAI
[ Thu, Nov 03rd 2022
] - WOPRAI
[ Thu, Nov 03rd 2022
] - WOPRAI
[ Thu, Nov 03rd 2022
] - WOPRAI
[ Thu, Nov 03rd 2022
] - WOPRAI
[ Thu, Nov 03rd 2022
] - WOPRAI
[ Thu, Nov 03rd 2022
] - WOPRAI
[ Thu, Nov 03rd 2022
] - WOPRAI
[ Thu, Nov 03rd 2022
] - WOPRAI
[ Thu, Nov 03rd 2022
] - WOPRAI
[ Thu, Nov 03rd 2022
] - WOPRAI
[ Thu, Nov 03rd 2022
] - WOPRAI
[ Thu, Nov 03rd 2022
] - WOPRAI
[ Thu, Nov 03rd 2022
] - WOPRAI
[ Thu, Nov 03rd 2022
] - WOPRAI
[ Thu, Nov 03rd 2022
] - WOPRAI
[ Thu, Nov 03rd 2022
] - WOPRAI
[ Thu, Nov 03rd 2022
] - WOPRAI
[ Thu, Nov 03rd 2022
] - WOPRAI
[ Thu, Nov 03rd 2022
] - WOPRAI
[ Thu, Nov 03rd 2022
] - WOPRAI
[ Thu, Nov 03rd 2022
] - WOPRAI
[ Thu, Nov 03rd 2022
] - WOPRAI
[ Thu, Nov 03rd 2022
] - WOPRAI
[ Thu, Nov 03rd 2022
] - WOPRAI
[ Thu, Nov 03rd 2022
] - WOPRAI
[ Thu, Nov 03rd 2022
] - WOPRAI
[ Thu, Nov 03rd 2022
] - WOPRAI
[ Thu, Nov 03rd 2022
] - WOPRAI
[ Thu, Nov 03rd 2022
] - WOPRAI
Matthew Mishan Maintained (AVNS) at Buy with Decreased Target to $34 on, Nov 3rd, 2022
Matthew Mishan of Keybanc, Maintained "Avanos Medical, Inc." (AVNS) at Buy with Decreased Target from $38 to $34 on, Nov 3rd, 2022.
Matthew has made no other calls on AVNS in the last 4 months.
There are 2 other peers that have a rating on AVNS. Out of the 2 peers that are also analyzing AVNS, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Rick Wise of "Stifel" Maintained at Hold with Decreased Target to $28 on, Monday, July 18th, 2022
This is the rating of the analyst that currently disagrees with Matthew
- Drew Ranieri of "Morgan Stanley" Maintained at Sell with Decreased Target to $24 on, Tuesday, October 11th, 2022
